Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 3.56% is 16% below its 5-year average of 4.22%, around the middle of its 5-year range (-7.97%–11.55%).
24.16% below its 12-month average of 4.69%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 5.47%.
EBITDA MARGIN
3.56%
EBITDA MARGIN AVG TTM
4.69%
EBITDA MARGIN AVG 3Y
4.76%
EBITDA MARGIN AVG 5Y
4.22%
EBITDA MARGIN AVG 10Y
5.69%
EBITDA MARGIN AVG 15Y
6.06%
EBITDA MARGIN AVG 20Y
6.72%
CURRENT VS TTM AVG
-24.16%
CURRENT VS 3Y AVG
-25.28%
CURRENT VS 5Y AVG
-15.64%
CURRENT VS 10Y AVG
-37.45%
CURRENT VS 15Y AVG
-41.22%
CURRENT VS 20Y AVG
-47.05%
Healthcare Services Group, Inc.
Market Cap
$1.46B
EBITDA Margin
3.56%
TTM Avg
4.69%
3Y Avg
4.76%
5Y Avg
4.22%
Market Cap
$1.44B
EBITDA Margin
36.35%
TTM Avg
36.35%
3Y Avg
36.35%
5Y Avg
36.35%
Market Cap
$1.49B
EBITDA Margin
5.15%
TTM Avg
0.72%
3Y Avg
-7.50%
5Y Avg
-11313.48%
Market Cap
$1.42B
EBITDA Margin
21.45%
TTM Avg
-50.92%
3Y Avg
-538.26%
5Y Avg
-378.46%
Market Cap
$1.53B
EBITDA Margin
33.84%
TTM Avg
32.51%
3Y Avg
-30.03%
5Y Avg
-1.40%
Market Cap
$1.39B
EBITDA Margin
-10195.54%
TTM Avg
-87388.52%
3Y Avg
-48181.08%
5Y Avg
-32386.50%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Services Group, Inc. (HCSG) | $1.46B | 3.56% | 4.69% | 4.76% | 4.22% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.44B | 36.35% | 36.35% | 36.35% | 36.35% |
| GH Research PLC (GHRS)vs › | $1.47B | N/A | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.49B | 5.15% | 0.72% | -7.50% | -11313.48% |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 21.45% | -50.92% | -538.26% | -378.46% |
| Certara, Inc. (CERT)vs › | $1.50B | 18.52% | 17.87% | 16.34% | 15.57% |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 33.84% | 32.51% | -30.03% | -1.40% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | -10195.54% | -87388.52% | -48181.08% | -32386.50% |
| Innoviva, Inc. (INVA)vs › | $1.53B | 47.98% | 50.86% | 52.39% | 67.36% |
Gross Margin
17.3%
EBITDA Margin
3.6%
Operating Margin
7.0%
Net Margin
6.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 5.47% |
| 2026-03-31 | 8.13% |
| 2025-12-31 | 6.30% |
| 2025-09-30 | 11.55% |
| 2025-06-30 | -7.97% |
| 2025-03-31 | 5.68% |
| 2024-12-31 | 4.08% |
| 2024-09-30 | 5.31% |
| 2024-06-30 | 0.48% |
| 2024-03-31 | 5.96% |
| 2023-12-31 | 8.27% |
| 2023-09-30 | -0.48% |
| 2023-06-30 | 3.22% |
| 2023-03-31 | 4.14% |
| 2022-12-31 | 5.56% |
| 2022-09-30 | 1.07% |
| 2022-06-30 | 3.16% |
| 2022-03-31 | 4.26% |
| 2021-12-31 | 1.26% |
| 2021-09-30 | 3.71% |
| 2021-06-30 | 4.60% |
| 2021-03-31 | 8.84% |
| 2020-12-31 | 8.92% |
| 2020-09-30 | 9.17% |
| 2020-06-30 | 7.33% |
| 2020-03-31 | 6.63% |
| 2019-12-31 | 6.03% |
| 2019-09-30 | 5.95% |
| 2019-06-30 | 5.74% |
| 2019-03-31 | 2.36% |
| 2018-12-31 | 8.34% |
| 2018-09-30 | 6.54% |
| 2018-06-30 | 6.83% |
| 2018-03-31 | 0.11% |
| 2017-12-31 | 7.14% |
| 2017-09-30 | 6.84% |
| 2017-06-30 | 7.20% |
| 2017-03-31 | 8.06% |
| 2016-12-31 | 8.11% |
| 2016-09-30 | 7.88% |
| 2016-06-30 | 7.92% |
| 2016-03-31 | 8.16% |
| 2015-12-31 | 3.39% |
| 2015-09-30 | 8.31% |
| 2015-06-30 | 7.86% |
| 2015-03-31 | 7.45% |
| 2014-12-31 | 6.76% |
| 2014-09-30 | -10.41% |
| 2014-06-30 | 7.22% |
| 2014-03-31 | 7.85% |
| 2013-12-31 | 2.28% |
| 2013-09-30 | 7.30% |
| 2013-06-30 | 7.67% |
| 2013-03-31 | 7.04% |
| 2012-12-31 | 7.42% |
| 2012-09-30 | 6.92% |
| 2012-06-30 | 7.36% |
| 2012-03-31 | 5.13% |
| 2011-12-31 | 6.25% |
| 2011-09-30 | 8.05% |
| 2011-06-30 | 7.23% |
| 2011-03-31 | 6.06% |
| 2010-12-31 | 7.13% |
| 2010-09-30 | 6.73% |
| 2010-06-30 | 8.02% |
| 2010-03-31 | 6.66% |
| 2009-12-31 | 5.89% |
| 2009-09-30 | 6.98% |
| 2009-06-30 | 7.24% |
| 2009-03-31 | 7.69% |
| 2008-12-31 | 7.73% |
| 2008-09-30 | 6.40% |
| 2008-06-30 | 7.75% |
| 2008-03-31 | 7.86% |
| 2007-12-31 | 8.11% |
| 2007-09-30 | 7.84% |
| 2007-06-30 | 8.41% |
| 2007-03-31 | 8.25% |
| 2006-12-31 | 7.78% |
| 2006-09-30 | 7.36% |
| 2006-06-30 | 7.61% |
| 2006-03-31 | 6.99% |
| 2005-12-31 | 7.00% |
| 2005-09-30 | 6.12% |
| 2005-06-30 | 6.08% |
| 2005-03-31 | 25.55% |
| 2004-12-31 | 5.78% |
| 2004-09-30 | 5.46% |
| 2004-06-30 | 5.32% |
| 2004-03-31 | 5.34% |
| 2003-12-31 | 4.23% |
| 2003-09-30 | 4.72% |
| 2003-06-30 | 4.97% |
| 2003-03-31 | 5.08% |
| 2002-12-31 | 4.56% |
| 2002-09-30 | 4.79% |
